Story
LENZ Therapeutics Stock Jumps on Q2 Revenue Beat, Accelerating Sales

Shares of LENZ Therapeutics jumped 7.7% in pre-market trading after the company released second-quarter 2026 financial results that significantly surpassed analyst expectations on both revenue and earnings per share.
Earnings Beat Drives Gains
For the second quarter, LENZ Therapeutics reported total revenue of $5.5 million, more than double the consensus forecast of approximately $2.5 million, according to its results published on the evening of August 11. The company's net loss was also narrower than anticipated at $1.02 per share, compared to an expected loss of $1.07 per share.
The strong top-line performance was driven by two key areas:
- Product Revenue: $1.7 million from the sale of 27,000 monthly VIZZ packs, an increase of 9% from the previous quarter.
- License Revenue: $3.8 million generated from international partnership agreements.
Commercial Momentum and Analyst Outlook
AdAdding to investor optimism, LENZ management highlighted that commercial momentum is accelerating into the third quarter. The company reported that prescriptions for its VIZZ product surged 45% in July, a sign of strengthening market adoption that is not fully captured in the second-quarter figures.
Following the report, analysts at Citi reiterated their Buy rating on the stock but reduced their price target to $10 from $20, reflecting what the source material described as a more measured view of the commercial ramp-up. The broader Wall Street consensus remains constructive, with six Buy ratings and one Hold rating on the stock.
Market Context
The rally was also supported by a positive tone in the broader market, which often benefits smaller-capitalization biotech stocks. The advance provides a degree of relief for shareholders who have seen the stock fall from a 52-week high of $50.40 to a low of $4.68 prior to this rebound.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.